Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Noriyoshi Miura
Keiichiro Mori
Hadi Mostafaei
Fahad Quhal
Reza Sari Motlagh
Mohammad Abufaraj
Benjamin Pradere
Abdulmajeed Aydh
Ekaterina Laukhtina
David D’Andrea
Takashi Saika
Shahrokh F. Shariat
机构：
[1] Comprehensive Cancer Center,Department of Urology
[2] Medical University of Vienna,Department of Urology
[3] Ehime University Graduate School of Medicine,Department of Urology
[4] The Jikei University School of Medicine,Research Center for Evidence based Medicine
[5] Tabriz University of Medical Sciences,Department of Urology
[6] King Fahad Specialist Hospital,Division of Urology, Department of Special Surgery, Jordan University Hospital
[7] The University of Jordan,Department of Urology
[8] University Hospital of Tours,Institute for Urology and Reproductive Health
[9] King Faisal Medical City,Department of Urology
[10] Sechenov University,Department of Urology
[11] Weill Cornell Medical College,Department of Urology, Second Faculty of Medicine
[12] University of Texas Southwestern,undefined
[13] Karl Landsteiner Institute of Urology and Andrology,undefined
[14] Charles University,undefined
[15] European Association of Urology Research Foundation,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Prostate cancer; Testosterone; Meta-analysis; Androgen receptor-targeted agents; Castration-resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1881 / 1891
页数：10
相关论文
共 50 条
  • [1] Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Miura, Noriyoshi
    Mori, Keiichiro
    Mostafaei, Hadi
    Quhal, Fahad
    Motlagh, Reza Sari
    Abufaraj, Mohammad
    Pradere, Benjamin
    Aydh, Abdulmajeed
    Laukhtina, Ekaterina
    D'Andrea, David
    Saika, Takashi
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1881 - 1891
  • [2] Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
    Song, Hualin
    Jin, Song
    Xiang, Peng
    Hu, Shuai
    Jin, Jie
    BMC CANCER, 2020, 20 (01)
  • [3] Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
    Hualin Song
    Song Jin
    Peng Xiang
    Shuai Hu
    Jie Jin
    BMC Cancer, 20
  • [4] Abiraterone for Treatment of Metastatic Castration-resistant Prostate Cancer: a Systematic Review and Meta-analysis
    Zhou, Zhi-Rui
    Liu, Shi-Xin
    Zhang, Tian-Song
    Xia, Jun
    Li, Bo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1313 - 1320
  • [5] Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer A Systematic Review and Network Meta-Analysis
    Liu, Zefu
    Zhang, Tong
    Ma, Zikun
    Zheng, Shiyang
    Chen, Junying
    Wu, Zhiming
    Zheng, Xia
    Li, Xiangdong
    Liu, Zhuowei
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (04): : 288 - 297
  • [6] Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
    Qin, Zhiqiang
    Li, Xiao
    Zhang, Jianzhong
    Tang, Jingyuan
    Han, Peng
    Xu, Zhen
    Yu, Yajie
    Yang, Chengdi
    Wang, Chengming
    Xu, Ting
    Xu, Zicheng
    Zou, Qing
    MEDICINE, 2016, 95 (39)
  • [7] The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
    Wang, Xing-Hui
    Wang, Zhi-Qiang
    Mu, Zhen-Yu
    Zhu, Li-Ping
    Zhong, Chong-Fu
    Guo, Shanchun
    MEDICINE, 2022, 101 (31) : E29715
  • [8] Meta-analysis of efficacy and safety of custirsen in patients with metastatic castration-resistant prostate cancer
    Zhang, Xuebao
    Liu, Chu
    Li, Kui
    Wang, Ke
    Zhang, Qiqiang
    Cui, Yuanshan
    MEDICINE, 2019, 98 (06)
  • [9] Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis
    Mohammadzadeh, Mohammad
    Shirmohammadi, Masoud
    Ghojazadeh, Morteza
    Nikniaz, Leila
    Raeisi, Mortaza
    Aghdas, Seyed Ali Mousavi
    PROSTATE INTERNATIONAL, 2018, 6 (04) : 119 - 125
  • [10] Fuzheng-Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysis
    Liang, Xiao
    Peng, Shirong
    Huang, Hai
    Xu, Jia
    Liu, Wenjuan
    Wang, Hailong
    Li, Qi
    MEDICINE, 2024, 103 (45) : e40275
12345